Lanserhof Group secures a €95 million investment from a consortium led by AltamarCAM Partners and King Street Capital Management to enhance its international growth and expand its luxury health resort offerings.
Target Company Overview
Lanserhof Group (“Lanserhof”) is a premier operator of luxury health resorts specializing in vitality, beauty, and longevity. Headquartered in Europe, the company operates three esteemed resorts in Lans, Austria, and Tegernsee and Sylt, Germany, with an additional location in development near Marbella, Spain. Lanserhof is widely acknowledged as a leader in preventive health, merging advanced diagnostics with innovative therapies and unparalleled luxury hospitality. Its unique approach focuses on bespoke wellness experiences tailored to individual needs, thereby fostering enduring health and enhancing longevity.
The resorts operate under the award-winning Lanserhof Concept, which intricately combines personalized fasting regimens with tailored therapeutic solutions, all delivered by an interdisciplinary team of health professionals. This integration of science and luxury hospitality aims to deliver lasting well-being for guests while meeting the growing demand for high-quality preventive health services.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Europe
The luxury health resort industry in Europe has experienced robust growth in recent years, fueled by a rising awareness of health and wellness among consumers. The increasing focus on preventive health measures has opened new avenues
Similar Deals
Growth Lending → A & R Care Limited
2025
New Mountain Capital → Smarter Technologies
2025
Kemin Industries → AFYREN
2025
InvAscent → Apex Hospitals Private Limited
2025
InvAscent → Geri Care Health Services
2025
Lead Ventures, J&T Ventures → XUND
2025
AltamarCAM Partners
invested in
Lanserhof Group
in 2025
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $95M